Konferenzschrift | Kongress
Differential pricing of pharmaceuticals inside Europe : exploring compulsory licenses and exhaustion for access to patented essential medicines
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783832942809
- Maße
-
23 cm
- Umfang
-
219 S.
- Ausgabe
-
1. Aufl.
- Sprache
-
Englisch
- Anmerkungen
-
graph. Darst.
Literaturangaben
- Erschienen in
-
Schriftenreihe des Zentrums für Europäische Rechtspolitik der Universität Bremen (ZERP) / Universität Bremen ; Bd. 58
- Schlagwort
-
Arzneimittelpreis
Preisdifferenzierung
Recht
Europa
- Ereignis
-
Veröffentlichung
- (wo)
-
Baden-Baden
- (wer)
-
Nomos
- (wann)
-
2010
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:06 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Konferenzschrift
- Kongress
Beteiligte
- Godt, Christine
- Nomos
Entstanden
- 2010
Ähnliche Objekte (12)
TRIPS flexibilities and access to medicines: An evaluation of barriers to employing compulsory licenses for patented pharmaceuticals at the WTO
The failure of compulsory licensing of pharmaceuticals in least developed countries
The failure of compulsory licensing of pharmaceuticals in least developed countries
Medicines Information and the Regulation of the Promotion of Pharmaceuticals
Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?
Is Compulsory Vaccination Compulsory?
Exhaustion, Non-exhaustion and Implied Licence
Special compulsory licences for export of medicines: Key features of WTO members' implementing legislation
Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: a cross-sectional analysis
Access to medicines: Experiences with compulsory licenses and government use - The case of Hepatitis C
Compulsory Arbitration.
Pharmaceuticals and Environment: a web-based decision support for considering environmental aspects of medicines in use
TRIPS flexibilities and access to medicines: An evaluation of barriers to employing compulsory licenses for patented pharmaceuticals at the WTO
The failure of compulsory licensing of pharmaceuticals in least developed countries
The failure of compulsory licensing of pharmaceuticals in least developed countries
Medicines Information and the Regulation of the Promotion of Pharmaceuticals
Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?
Is Compulsory Vaccination Compulsory?
Exhaustion, Non-exhaustion and Implied Licence
Special compulsory licences for export of medicines: Key features of WTO members' implementing legislation
Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: a cross-sectional analysis
Access to medicines: Experiences with compulsory licenses and government use - The case of Hepatitis C
Compulsory Arbitration.
Pharmaceuticals and Environment: a web-based decision support for considering environmental aspects of medicines in use
TRIPS flexibilities and access to medicines: An evaluation of barriers to employing compulsory licenses for patented pharmaceuticals at the WTO
The failure of compulsory licensing of pharmaceuticals in least developed countries
The failure of compulsory licensing of pharmaceuticals in least developed countries
Medicines Information and the Regulation of the Promotion of Pharmaceuticals
Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?
Is Compulsory Vaccination Compulsory?
Exhaustion, Non-exhaustion and Implied Licence
Special compulsory licences for export of medicines: Key features of WTO members' implementing legislation
Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: a cross-sectional analysis
Access to medicines: Experiences with compulsory licenses and government use - The case of Hepatitis C
Compulsory Arbitration.